ArticleJournal of Cancer2021

Efficacy of second-line treatments for patients with advanced human epidermal growth factor receptor 2 positive breast cancer after trastuzumab-based treatment: a systematic review and bayesian network analysis.

Fei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.